ARROW MAGNOLIA INTERNATIONAL INC
SC 13D/A, 1999-10-08
MISCELLANEOUS CHEMICAL PRODUCTS
Previous: ADC TELECOMMUNICATIONS INC, S-8, 1999-10-08
Next: MELLON BANK CORP, SC 13G/A, 1999-10-08




                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                              --------------------

                                  SCHEDULE 13D
                                 (Rule 13d-101)

             INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
            TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
                                  RULE 13d-2(a)

                                (Amendment No. 1)

                        Arrow Magnolia International Inc.
- --------------------------------------------------------------------------------
                                (Name of Issuer)

                                  Common Stock
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                    042768101
- --------------------------------------------------------------------------------
                                 (CUSIP Number)

                                  Morris Swift
              2646 Rodney Lane, Dallas, Texas 75299 (972) 247-7111
- --------------------------------------------------------------------------------
                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                               September 30, 1999
- --------------------------------------------------------------------------------
             (Date of Event Which Requires Filing of This Statement)

      If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box |_|.

            Note. Schedules filed in paper format shall include a signed
      original and five copies of the schedule, including all exhibits. See Rule
      13d-7(b) for other parties to whom copies are to be sent.

                         (Continued on following pages)

                               (Page 1 of 2 Pages)

- ----------
      (1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.

      The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

<PAGE>

CUSIP No. 042768 10 1              SCHEDULE 13D                Page 2 of 2 Pages
- --------------------------------------------------------------------------------
1     NAMES OF REPORTING PERSONS
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

      Shoreline Micro-Cap Fund I, L.P.
      36-4267056
- --------------------------------------------------------------------------------
2     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                        (a)  |_|
                                                                        (b)  |x|
- --------------------------------------------------------------------------------
3     SEC USE ONLY


- --------------------------------------------------------------------------------
4     SOURCE OF FUNDS*

      WC
- --------------------------------------------------------------------------------
5     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
      TO ITEM 2(d) or 2(e)                                                   |_|

- --------------------------------------------------------------------------------
6     CITIZENSHIP OR PLACE OF ORGANIZATION

      222 West Adams Street, Chicago, Illinois 60606-5307
- --------------------------------------------------------------------------------
                  7     SOLE VOTING POWER

                        199,700
                        --------------------------------------------------------
  NUMBER OF       8     SHARED VOTING POWER
   SHARES
BENEFICIALLY
  OWNED BY              --------------------------------------------------------
    EACH          9     SOLE DISPOSITIVE POWER
  REPORTING
   PERSON               199,700
    WITH                --------------------------------------------------------
                  10    SHARED DISPOSITIVE POWER


- --------------------------------------------------------------------------------
11    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

      199,700
- --------------------------------------------------------------------------------
12    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
      CERTAIN SHARES*                                                        |_|

- --------------------------------------------------------------------------------
13    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

      6.1%
- --------------------------------------------------------------------------------
14    TYPE OF REPORTING PERSON*

      IV
- --------------------------------------------------------------------------------

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!

<PAGE>

Item 1. Security and Issuer

      This statement relates to common stock of Arrow Magnolia International
Inc. (the "Company"). The principal executive offices of the Company are located
at 2646 Rodney Lane, Dallas, Texas 75299.

Item 2. Identity and Background

(a)   This Schedule 13D is filed on behalf of Shoreline Micro-Cap Fund I, L.P.,
      an Illinois limited partnership (the "Fund").

(b)   The business address of the Fund is as follows:

      Shoreline Micro-Cap Fund I, L.P.
      c/o William Blair & Company, L.L.C.
      222 West Adams Street
      Chicago, Illinois 60606

(c)   The Fund was formed for the purposes of making investments in micro-cap
      companies.

(d)   None of the limited partners or general partner of the Fund has, during
      the last five years, been convicted in a criminal proceeding (excluding
      traffic violations or similar misdemeanors).

(e)   None of the limited partners or general partner has, during the last five
      years, been a party to any civil proceeding of a judicial or
      administrative body of competent jurisdiction and as a result of which
      such person was or is subject to a judgment, decree, or final order
      enjoining future violations of, or prohibiting or mandating activities
      with respect to, federal or state securities laws or a finding of any
      violations with respect to such laws.

(f)   Not applicable.

Item 3. Source and Amount of Funds or Other Considerations

      The funds for the acquisition of the additional purchase of common stock
of the Company consisted of working capital invested in the Fund by its limited
partners and general partner. The amount of the transactions that are the
subject of this amendment as approximately $103,585.50.

Item 4. Purpose of Transaction

      The common stock of the Company was purchased by the Fund for investment
only. Therefore, the plans of the Fund with respect to the common stock of the
Company do not relate to and would not result in any of the items enumerated in
(a)-(j) of Item 4.

<PAGE>

Item 5. Interest in Securities of the Issuer

(a)   As of October 7, 1999, the Fund owns 199,700 shares of the common stock of
      the Company, which equals 6.1% of the outstanding shares of the common
      stock of the Company.

(b)   The Fund owns 199,700 shares of the common stock of the Company over which
      the Fund has the sole power to vote or to direct the vote and sole power
      to dispose or to direct the disposition of such shares.

(c)   The Fund has effected the following purchases of the common stock of the
      Company (totaling 34,700 shares) since the filing of the original Schedule
      13D on August 5, 1999:

      9/30/99    5,000 shares at $3.50 per share
      9/17/99      800 shares at $3.50 per share
      9/10/99    1,200 shares at $3.50 per share
      9/8/99     1,000 shares at $3.50 per share
      8/6/99    26,700 shares at $3.38 per share

      The transactions were all effected through the Fund's brokerage account at
William Blair & Company, L.L.C.

(d)   Not applicable.

(e)   Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to
        Securities of the Issuer

      No contracts, arrangements, understandings or relationships (legal or
otherwise) exist among the Fund and any other person or persons with respect to
the securities of the issuer.

Item 7. Material to Be Filed as Exhibits

      No material is being filed as exhibits.

<PAGE>

Signature

      After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.


Date: October 7, 1999                    Signature: /s/ Richard P. Kiphart
                                                    ----------------------------
                                                    Title: General Partner



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission